Literature DB >> 20954235

Recognition of Smac-mimetic compounds by the BIR domain of cIAP1.

Federica Cossu1, Francesca Malvezzi, Giulia Canevari, Eloise Mastrangelo, Daniele Lecis, Domenico Delia, Pierfausto Seneci, Carlo Scolastico, Martino Bolognesi, Mario Milani.   

Abstract

Inhibitor of apoptosis proteins (IAPs) are negative regulators of apoptosis. As IAPs are overexpressed in many tumors, where they confer chemoresistance, small molecules inactivating IAPs have been proposed as anticancer agents. Accordingly, a number of IAP-binding pro-apoptotic compounds that mimic the sequence corresponding to the N-terminal tetrapeptide of Smac/DIABLO, the natural endogenous IAPs inhibitor, have been developed. Here, we report the crystal structures of the BIR3 domain of cIAP1 in complex with Smac037, a Smac-mimetic known to bind potently to the XIAP-BIR3 domain and to induce degradation of cIAP1, and in complex with the novel Smac-mimetic compound Smac066. Thermal stability and fluorescence polarization assays show the stabilizing effect and the high affinity of both Smac037 and Smac066 for cIAP1- and cIAP2-BIR3 domains.
Copyright © 2010 The Protein Society.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20954235      PMCID: PMC3009409          DOI: 10.1002/pro.523

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Expression and localization of inhibitor of apoptosis proteins in normal human tissues.

Authors:  Barbara Vischioni; Paul van der Valk; Simone W Span; Frank A E Kruyt; Jose A Rodriguez; Giuseppe Giaccone
Journal:  Hum Pathol       Date:  2005-11-17       Impact factor: 3.466

3.  Solvent content of protein crystals.

Authors:  B W Matthews
Journal:  J Mol Biol       Date:  1968-04-28       Impact factor: 5.469

4.  Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins.

Authors:  A M Verhagen; P G Ekert; M Pakusch; J Silke; L M Connolly; G E Reid; R L Moritz; R J Simpson; D L Vaux
Journal:  Cell       Date:  2000-07-07       Impact factor: 41.582

5.  Autocrine TNFalpha signaling renders human cancer cells susceptible to Smac-mimetic-induced apoptosis.

Authors:  Sean L Petersen; Lai Wang; Asligul Yalcin-Chin; Lin Li; Michael Peyton; John Minna; Patrick Harran; Xiaodong Wang
Journal:  Cancer Cell       Date:  2007-11       Impact factor: 31.743

6.  Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.

Authors:  Eloise Mastrangelo; Federica Cossu; Mario Milani; Graziella Sorrentino; Daniele Lecis; Domenico Delia; Leonardo Manzoni; Carmelo Drago; Pierfausto Seneci; Carlo Scolastico; Vincenzo Rizzo; Martino Bolognesi
Journal:  J Mol Biol       Date:  2008-10-07       Impact factor: 5.469

7.  Novel SMAC-mimetics synergistically stimulate melanoma cell death in combination with TRAIL and Bortezomib.

Authors:  D Lecis; C Drago; L Manzoni; P Seneci; C Scolastico; E Mastrangelo; M Bolognesi; A Anichini; H Kashkar; H Walczak; D Delia
Journal:  Br J Cancer       Date:  2010-05-11       Impact factor: 7.640

8.  IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis.

Authors:  James E Vince; W Wei-Lynn Wong; Nufail Khan; Rebecca Feltham; Diep Chau; Afsar U Ahmed; Christopher A Benetatos; Srinivas K Chunduru; Stephen M Condon; Mark McKinlay; Robert Brink; Martin Leverkus; Vinay Tergaonkar; Pascal Schneider; Bernard A Callus; Frank Koentgen; David L Vaux; John Silke
Journal:  Cell       Date:  2007-11-16       Impact factor: 41.582

9.  Structural basis for bivalent Smac-mimetics recognition in the IAP protein family.

Authors:  Federica Cossu; Mario Milani; Eloise Mastrangelo; Patrice Vachette; Federica Servida; Daniele Lecis; Giulia Canevari; Domenico Delia; Carmelo Drago; Vincenzo Rizzo; Leonardo Manzoni; Pierfausto Seneci; Carlo Scolastico; Martino Bolognesi
Journal:  J Mol Biol       Date:  2009-04-22       Impact factor: 5.469

10.  The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.

Authors:  Raviraj Kulathila; Brian Vash; David Sage; Susan Cornell-Kennon; Kirk Wright; James Koehn; Travis Stams; Kirk Clark; Allen Price
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2008-12-18
View more
  10 in total

1.  Expression of executioner procaspases and their activation by a procaspase-activating compound in chronic lymphocytic leukemia cells.

Authors:  Viralkumar Patel; Kumudha Balakrishnan; Michael J Keating; William G Wierda; Varsha Gandhi
Journal:  Blood       Date:  2014-12-23       Impact factor: 22.113

2.  Expedient synthesis of highly potent antagonists of inhibitor of apoptosis proteins (IAPs) with unique selectivity for ML-IAP.

Authors:  Mitchell Vamos; Kate Welsh; Darren Finlay; Pooi San Lee; Peter D Mace; Scott J Snipas; Monica L Gonzalez; Santhi Reddy Ganji; Robert J Ardecky; Stefan J Riedl; Guy S Salvesen; Kristiina Vuori; John C Reed; Nicholas D P Cosford
Journal:  ACS Chem Biol       Date:  2013-02-05       Impact factor: 5.100

3.  The SMAC mimetic BV6 induces cell death and sensitizes different cell lines to TNF-α and TRAIL-induced apoptosis.

Authors:  Mohamed El-Mesery; Mohamed E Shaker; Abdelaziz Elgaml
Journal:  Exp Biol Med (Maywood)       Date:  2016-07-28

4.  Derivatives of Procaspase-Activating Compound 1 (PAC-1) and their Anticancer Activities.

Authors:  Howard S Roth; Paul J Hergenrother
Journal:  Curr Med Chem       Date:  2016       Impact factor: 4.530

5.  Unique BIR domain sets determine inhibitor of apoptosis protein-driven cell death and NOD2 complex signal specificity.

Authors:  Steven M Chirieleison; Joseph K Rathkey; Derek W Abbott
Journal:  Sci Signal       Date:  2018-07-17       Impact factor: 8.192

6.  Structural insight into inhibitor of apoptosis proteins recognition by a potent divalent smac-mimetic.

Authors:  Federica Cossu; Mario Milani; Patrice Vachette; Francesca Malvezzi; Serena Grassi; Daniele Lecis; Domenico Delia; Carmelo Drago; Pierfausto Seneci; Martino Bolognesi; Eloise Mastrangelo
Journal:  PLoS One       Date:  2012-11-15       Impact factor: 3.240

7.  The structure of XIAP BIR2: understanding the selectivity of the BIR domains.

Authors:  Christine Lukacs; Charles Belunis; Robert Crowther; Waleed Danho; Lin Gao; Barry Goggin; Cheryl A Janson; Shirley Li; Stacy Remiszewski; Andrew Schutt; Manish K Thakur; Saroj K Singh; Srinivasan Swaminathan; Rajat Pandey; Rajiv Tyagi; Ramachandraiah Gosu; Ajith V Kamath; Andreas Kuglstatter
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2013-08-15

8.  Characterization of Potent SMAC Mimetics that Sensitize Cancer Cells to TNF Family-Induced Apoptosis.

Authors:  Kate Welsh; Snezana Milutinovic; Robert J Ardecky; Marcos Gonzalez-Lopez; Santhi Reddy Ganji; Peter Teriete; Darren Finlay; Stefan Riedl; Shu-Ichi Matsuzawa; Clemencia Pinilla; Richard Houghten; Kristiina Vuori; John C Reed; Nicholas D P Cosford
Journal:  PLoS One       Date:  2016-09-12       Impact factor: 3.240

9.  Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.

Authors:  Kumudha Balakrishnan; Min Fu; Francesco Onida; William G Wierda; Michael J Keating; Varsha Gandhi
Journal:  Oncotarget       Date:  2016-06-28

10.  Investigation of Hot Spot Region in XIAP Inhibitor Binding Site by Fragment Molecular Orbital Method.

Authors:  Hocheol Lim; Xuemei Jin; Jongwan Kim; Sungbo Hwang; Ki Beom Shin; Jiwon Choi; Ky-Youb Nam; Kyoung Tai No
Journal:  Comput Struct Biotechnol J       Date:  2019-08-21       Impact factor: 7.271

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.